The pharmaceutically acceptable salts of bicycle-substituted pyrazolon azo derivatives represented by the general formula (I) their preparation methods pharmaceutical compositions containing the same and their use as a therapeutic agent especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor. The definitions of substituents in the general formula (I) are the same as the description.